Abstract
The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.
Original language | English (US) |
---|---|
Pages (from-to) | 20-30 |
Number of pages | 11 |
Journal | Kidney international |
Volume | 87 |
Issue number | 1 |
DOIs | |
State | Published - Jan 3 2015 |
Bibliographical note
Publisher Copyright:© 2015 International Society of Nephrology.
Keywords
- Albuminuria
- blood pressure
- diabetic kidney disease
- glycemic control
- lipid management